Ajanta Pharma Clarifies No Interest in Restaurant Brands Asia Acquisition

0 min read     Updated on 20 Jan 2026, 10:25 AM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Ajanta Pharma has officially denied any interest in acquiring shares of Restaurant Brands Asia, according to Reuters reports. The pharmaceutical company's clarification addresses market speculation and provides clarity about its investment strategy, confirming it has not explored purchasing shares in the restaurant chain operator.

30430536

*this image is generated using AI for illustrative purposes only.

Ajanta Pharma has officially clarified that it has not considered purchasing shares in Restaurant Brands Asia, according to Reuters reports. The pharmaceutical company's statement addresses any market speculation regarding potential investment interest in the restaurant chain operator.

Official Company Statement

The clarification from Ajanta Pharma comes as a direct response to market queries about potential acquisition interest. The company has explicitly stated that it has not looked into buying shares in Restaurant Brands Asia, putting to rest any speculation about cross-sector investment plans.

Market Implications

This official statement provides clarity to investors and market participants about Ajanta Pharma's current investment strategy. The pharmaceutical company's focus appears to remain within its core business areas rather than diversifying into the restaurant and food service sector.

Company Details: Information
Clarifying Company: Ajanta Pharma
Target Company: Restaurant Brands Asia
Investment Interest: None confirmed
Source: Reuters

The statement helps eliminate any uncertainty in the market regarding potential corporate actions between these two companies operating in different sectors.

Historical Stock Returns for Ajanta Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-0.05%-1.66%+1.96%-3.20%-6.82%+124.14%
Ajanta Pharma
View in Depthredirect
like15
dislike

Promoter Pledges Rise in Ajanta Pharma, Lloyds Metals, and Emami During Q3FY26

2 min read     Updated on 19 Jan 2026, 10:11 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Ajanta Pharma, Lloyds Metals and Energy, and Emami experienced promoter pledge increases during Q3FY26, with levels reaching 17.29%, 14.42%, and 11.60% respectively. Ajanta Pharma recorded the highest increase at 2.01%, while Lloyds Metals and Emami saw increases of 1.28% and 1.62%. Despite these pledge rises, all companies maintained stable promoter holdings, indicating continued ownership commitment and confidence in business fundamentals.

30386468

*this image is generated using AI for illustrative purposes only.

Promoter pledging activity increased across three notable companies during Q3FY26, with Ajanta Pharma , Lloyds Metals and Energy, and Emami witnessing rises in pledge levels by up to 2%. Promoter pledge represents the portion of a promoter's shareholding offered as collateral to secure loans, helping fund business requirements or personal obligations. While this practice provides financial flexibility, elevated pledge levels can increase shareholder risk through potential margin calls and sudden selling pressure during adverse market movements.

Ajanta Pharma Shows Highest Pledge Increase

Ajanta Pharma, a specialty pharmaceutical company with strong presence in branded generics across emerging markets, recorded the most significant pledge increase during the quarter. The company has established leadership positions in therapeutic segments including ophthalmology, cardiology, and dermatology, supported by in-house research and development capabilities.

Parameter: Details
Market Capitalization: ₹33,315 crores
Share Price: ₹2,666 per share
Quarterly Price Change: -0.54%
Promoter Holding Range: 66.2% - 66.3% (Dec 2023 to Dec 2025)
Current Pledge Level: 17.29%
Quarterly Pledge Increase: 2.01%

Promoter holding has remained remarkably stable within a narrow range of 66.2% to 66.3% from December 2023 to December 2025, demonstrating consistent ownership commitment over eight quarters. However, promoter pledging has risen from 12.3% in December 2023 to 17.29% in December 2025, with the latest quarter contributing an additional 2.01% increase.

Lloyds Metals Records Moderate Pledge Rise

Lloyds Metals and Energy, an integrated iron ore mining and sponge iron producer with operations centered in Maharashtra, experienced a moderate increase in promoter pledging. The company has gained recognition for its captive mining assets, improving infrastructure, and strategic cost efficiency focus.

Metric: Current Status
Market Capitalization: ₹65,609 crores
Share Price: ₹1,205 per share
Quarterly Price Change: -1.93%
Promoter Holding: 63.7% (Dec 2025)
Pledge Level: 14.42%
Latest Quarter Increase: 1.28%

Promoter holding has maintained stability in the 63% to 64% range over six quarters, moving from 63.5% in July 2024 to 63.7% in December 2025. Notably, promoter pledging has declined significantly from a peak of 24.5% in July 2024 to the current 14.42%, though the latest quarter saw a 1.28% increase from the previous 13.1% level.

Emami Witnesses Modest Pledge Increase

Emami, a leading Indian FMCG company with strong presence in personal care, healthcare, and wellness products, recorded a modest increase in promoter pledging. The company is known for popular brands like Navratna and BoroPlus, combining extensive rural reach with consistent innovation.

Financial Highlights: Details
Market Capitalization: ₹22,004 crores
Share Price: ₹504 per share
Quarterly Price Change: -0.28%
Promoter Holding: 54.8% (unchanged since Dec 2023)
Current Pledge Level: 11.60%
Quarterly Pledge Addition: 1.62%

Promoter holding has remained unchanged at 54.8% from December 2023 to December 2025, reflecting exceptional ownership stability over eight quarters. Promoter pledging showed fluctuation, declining from 13.3% in December 2023 to a low of 8.2% in September 2024, before rising to the current 11.60% with a 1.62% increase in the latest quarter.

Monitoring Requirements

While all three companies maintain stable promoter holdings indicating sustained confidence, the recent increases in pledge levels warrant careful monitoring. The pledge levels remain manageable but represent potential risks during market volatility, as sharp price movements can trigger margin calls and create selling pressure.

Historical Stock Returns for Ajanta Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-0.05%-1.66%+1.96%-3.20%-6.82%+124.14%
Ajanta Pharma
View in Depthredirect
like20
dislike
More News on Ajanta Pharma
Explore Other Articles
2,684.20
-1.40
(-0.05%)